Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence

Nebraska Symposium on Motivation

Volumn 55, Issue , 2009, Pages 31-63

  Dwoskin, Linda P ^a   Pivavarchyk, Marharyta ^b   Joyce, B Matthew ^b   Neugebauer, Nichole M ^b   Zheng, Guangrong ^b   Zhang, Zhenfa ^b   Bardo, Michael T ^b   Crooks, Peter A ^b  

^a University of Kentucky   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA-BUNGAROTOXIN RECEPTOR; AMFEBUTAMONE; BENZAZEPINE DERIVATIVE; BUNGAROTOXIN RECEPTOR; DOPAMINE; N,N' DODECANE 1,12 DIYL BIS 3 PICOLINIUM DIBROMIDE; N,N'-DODECANE-1,12-DIYL-BIS-3-PICOLINIUM DIBROMIDE; NEW DRUG; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PICOLINE DERIVATIVE; QUATERNARY AMMONIUM DERIVATIVE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG; VARENICLINE;

ANIMAL; ARTICLE; BRAIN; DOSE RESPONSE; DRUG EFFECT; FISCHER 344 RAT; MALE; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RAT; REWARD; SMOKING CESSATION; SPRAGUE DAWLEY RAT; STRUCTURE ACTIVITY RELATION; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM;

ANIMALS; BENZAZEPINES; BRAIN; BUPROPION; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, INVESTIGATIONAL; MALE; NEURONS; NICOTINE; NICOTINIC ANTAGONISTS; PICOLINES; QUATERNARY AMMONIUM COMPOUNDS; QUINOXALINES; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; REWARD; SMOKING CESSATION; STRUCTURE-ACTIVITY RELATIONSHIP; TOBACCO USE DISORDER; VENTRAL TEGMENTAL AREA;

EID: 58149459517     PISSN: 01467875     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78748-0_4     Document Type: Conference Paper

References (147)

1. Alkondon, M., Pereira, E. F., Wonnacott, S., & Albuquerque, E. X. (1992). Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Molecular Pharmacology, 41(4), 802-808. (Pubitemid 23021472)
2. Allen, D. D., Lockman, P. R., Roder, K. E., Dwoskin, L. P., & Crooks, P. A. (2003). Active transport of high affinity choline and nicotine analogs into the central nervous system by the blood brain barrier choline transporter. Journal of Pharmacology and Experimental Therapeutics, 304, 1268-1274. (Pubitemid 36254440)
3. Anand, R., Conroy, W. G., Schoepfer, R., Whiting, P., & Lindstrom, J. (1991). Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. Journal of Biological Chemistry, 266(17), 11192-11198. (Pubitemid 21906931)
4. Ayers, J. T., Clauset, A., Schmitt, J. D., Dwoskin, L. P., & Crooks, P. A. (2005). Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the alpha4beta2 nicotinic acetylcholine receptor subtype using nonlinear techniques. The AAPS Journal, 7(3), E678-E685.
5. Ayers, J. T., Dwoskin, L. P., Deaciuc, A. G., Grinevich, V. P., Zhu, J., & Crooks, P. A. (2002). Bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha 7* subtypes of neuronal nicotinic receptors. Bioorganic & Medicinal Chemistry Letters, 12(21), 2067-3071.
6. Azam, L., Winzer-Serhan, U. H., Chen, Y., & Leslie, F. M. (2002). Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. Journal of Comparative Neurology, 444(3), 260-274. (Pubitemid 34117090)
7. Balfour, D. J. (2002). The neurobiology of tobacco dependence: a commentary. Respiration, 69, 7-11. (Pubitemid 34158380)
8. Balfour, D. J. (2004). The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens. Nicotine & Tobacco Research, 6(6), 899-912. (Pubitemid 40124750)
9. Bardo, M. T. (1998). Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Critical Reviews in Neurobiology, 12(1-2), 37-67. (Pubitemid 28177263)
10. Benwell, M. E., & Balfour, D. J. (1992). The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. British Journal of Pharmacology, 105(4), 849-456.
11. Benwell, M. E., Balfour, D. J., & Birrell, C. E. (1995). Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. British Journal of Pharmacology, 114(2), 454-460.
12. Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Research Brain Research Reviews, 28, 309-369. (Pubitemid 29012677)
13. Bonci, A., Bernardi, G., Grillner, P., & Mercuri, N. B. (2003). the Dopamine-containing Neuron: Maestro or Simple Musician in the Orchestra of Addiction? Trends in Pharmacological Sciences, 24(4), 172-177
14. Brazell, M. P.,Mitchell, S. N., Joseph, M. H., & Gray, J. A. (1990). Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudateputamen. Neuropharmacology, 29(12), 1177-1185.
15. Brody, A. L., Mandelkern, M. A., Lee, G., Smith, E., Sadeghi, M., Saxena, S., et al. (2004). Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropiontreated smokers: a preliminary study. Psychiatry Research, 130(3), 269-281. (Pubitemid 38595428)
16. Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., et al. (2002). Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology, 163: 230-237. (Pubitemid 35013615)
17. Castro, N. G., & Albuquerque, E. X. (1995). alpha-Bungarotoxin- sensitive hippocampal nicotinic receptor channel has a high calcium permeability. Biophysical Journal, 68(2), 516-524.
18. Champtiaux, N., Gotti, C., Cordero-Erausquin, M., David, D. J., Przybylski, C., Lena, C., et al., (2003). Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. The Journal of Neuroscience, 23(21), 7820-7829. (Pubitemid 37055453)
19. Charpantier, E., Barneoud, P., Moser, P., Besnard, F., & Sgard, F. (1998). Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport, 9(13), 3097-3101. (Pubitemid 28555653)
20. Clarke, P. B., & Pert, A. (1985). Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Research, 348(2), 355-358. (Pubitemid 16231720)
21. Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., et al. (2005). Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. Journal of Medicinal Chemistry, 48(10), 3474-3477. (Pubitemid 40664098)
22. Conroy, W. G., Vernallis, A. B., & Berg, D. K. (1992). The alpha 5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain. Neuron, 9(4), 670-691.
23. Cooper, E., Couturier, S., & Ballivet, M. (1991). Pentameric structure and subunit stoichiometry of a neuronal acetylcholine receptor. Nature, 350(6315), 235-238. (Pubitemid 21912207)
24. Corrigall, W. A. (1999). Nicotine self-administration in animals as a dependence model. Nicotine & Tobacco Research, 1(1), 11-20.
25. Corrigall, W. A., & Coen, K. M. (1989). Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl), 99(4), 473-478. (Pubitemid 19273101)
26. Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research, 653(1-2), 278-284. (Pubitemid 24252850)
27. Corrigall, W. A., Franklin, K. B., Coen, K. M., & Clarke, P. B. (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl),107(2-3), 285-289.
28. Corringer, P. J., Sallette, J., & Changeux, J. P. (2006). Nicotine enhances intracellular nicotinic receptor maturation: a novel mechanism of neural plasticity? Journal of Physiology, Paris, 99(2-3), 162-171.
29. Crooks P. A., & Dwoskin L. P. (1997). Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. BiochemicalPharmacology, 54, 743-753. (Pubitemid 27404675)
30. Crooks, P. A., Ayers, J. T., Haubner, A. J., Grinevich, V. P., Sumithran, S. P., Deaciuc, A. G., et al. (2002) The bis-picolinium salt, bPiDDB, is a potent and selective antagonist at nicotinic acetylcholine receptors mediating nicotine-evoked dopamine release in rat striatum. Drug and Alcohol Dependence, 64, 38.
31. Crooks, P. A., Ayers, J. T., Xu, R., Sumithran, S. P., Grinevich, V. P., Wilkins, L. H., Deaciuc, A. G., Allen, D. D., & Dwoskin, L. P. (2004). Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release. Bioorganic & Medicinal Chemistry Letters, 14(8), 1869-1874. (Pubitemid 38410854)
32. Cui, C., Booker, T. K., Allen, R. S., Grady, S. R.,Whiteaker, P., Marks, M. J., et al. (2003). The β3 nicotinic receptor subunit: A component of α-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. Journal of Neuroscience, 23, 11045-11053. (Pubitemid 37548938)
33. Dani, J. A. (2003). Roles of dopamine signaling in nicotine addiction. Molecular Psychiatry, 8(3), 255-256. (Pubitemid 36712916)
34. Dani, J. A., & Bertrand, D. (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology, 47, 699-729.
35. Dani, J. A., & De Biasi, M. (2001). Cellular mechanisms of nicotine addiction. Pharmacology, Biochemistry and Behavior, 70(4), 439-446. (Pubitemid 34131638)
36. Dani, J. A., & Harris, R. A. (2005). Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nature Neuroscience, 8(11), 1465-1470. (Pubitemid 41573657)
37. Dani, J. A., Ji, D., & Zhou, F. M. (2001). Synaptic plasticity and nicotine addiction. Neuron, 31(3), 349-352. (Pubitemid 32778555)
38. Deneris, E. S., Boulter, J., Swanson, L. W., Patrick, J., & Heinemann, S. (1989). Beta 3: a new member of nicotinic acetylcholine receptor gene family is expressed in the brain. Journal of Biological Chemistry, 264(11), 6268-6272. (Pubitemid 19106702)
39. Di Chiara, G. (2000). Role of dopamine in the behavioural actions of nicotine related to addiction. European Journal of Pharmacology, 393, 295-314. (Pubitemid 30193428)
40. Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V., & Lecca, D. (2004). Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology, 47, 227-241. (Pubitemid 39298267)
41. Dwoskin, L. P., Sumithran, S. P., Zhu, J., Deaciuc, A. G., Ayers, J. T., & Crooks, P. A. (2004). Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents. Bioorganic & Medicinal Chemistry Letters, 14, 1863-1867. (Pubitemid 38410853)
42. Dwoskin, L. P., Teng, L. H., Buxton, S. T., Ravard, A., Deo, N., & Crooks, P. A. (1995). Minor alkaloids of tobacco release [3H]dopamine release from superfused rat striatal slices. European. Journal of. Pharmacology, 276,195-199.
43. Donny, E. C., Chaudhri, N., Caggiula, A. R., Evans-Martin, F. F., Booth, S., Gharib, M. A., et al. (2003). Operant responding for a visual reinforcer in rats in enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl), 169(1), 68-76. (Pubitemid 37088616)
44. Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992). A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Molecular Pharmacology, 41(1), 31-37.
45. Forsayeth, J. R., & Kobrin, E. (1997). Formation of oligomers containing the beta 3 and beta 4 subunits of the rat nicotinic receptor. Journal of Neuroscience, 17(5), 1531-1538. (Pubitemid 27089799)
46. Fu, Y., Matta, S. G., Gao,W., & Sharp, B. M. (2000). Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo. Neuroscience, 101(2), 369-375.
47. Ghosheh, O., Dwoskin, L. P., Li, W. K., & Crooks, P. A. (1999). Residence time and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2'-14C]nicotine. Drug Metabolism and Disposition, 27, 1448-1455.
48. Ghosheh O. A., Dwoskin L. P., Miller D. K. and Crooks P. A. (2001). Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2'-14C]-nicotine. Drug Metabolism and Disposition, 29, 645-651. (Pubitemid 32374564)
49. George, T. P., & O'Malley, S. S. (2004). Current pharmacological treatments for nicotine dependence. Trends in Pharmacological Sciences, 25(1), 42-48. (Pubitemid 38081281)
50. Goldner, F. M., Dineley, K. T., & Patrick, J. W. (1997). Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha 6 to dopaminergic neurons in the substantia nigra and ventral tegmental area. Neuroreport, 8(12), 2739-2742. (Pubitemid 27373522)
51. Gotti, C., Moretti, M., Clementi, F., Riganti, F., McIntosh, J. M., Collins, A. C., et al. (2005). Expression of nigrostriatal α6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by β3 subunit gene deletion. Molecular Pharmacology, 67, 2007-2015. (Pubitemid 41007782)
52. Gotti, C., Zoli, M., & Clementi, F. (2006). Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends in Pharmacological Sciences, 27(9), 482-491. (Pubitemid 44251225)
53. Grady, S. R., Grun, E. U., Marks, M. J., & Collins, A. C. (1997). Pharmacological comparisons of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment. The Journal of Pharmacology and Experimental Therapeutics, 282, 32-43. (Pubitemid 27425524)
54. Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J-P., et al. (2001). Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. Journal of Neurochemistry, 76, 258-226.
55. Grady, S. R., Murphy, K. L., Cao, J., Marks, M. J., McIntosh, J. M., & Collins, A. C. (2002). Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. Journal of Pharmacology and Experimental Therapeutics, 301(2), 651-660. (Pubitemid 34429981)
56. Gray, R., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996). Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature, 383(6602), 713-716. (Pubitemid 26360646)
57. Grinevich, V. P., Crooks, P. A., Sumithran, S. P., Haubner, A. J., Ayers, J. T., & Dwoskin, L. P. (2003). N-n-Alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H]dopamine overflow from superfused rat striatal slices. The Journal of Pharmacology and Experimental Therapeutics, 306(3), 1011-1020. (Pubitemid 37025308)
58. Grottick, A. J., Trube, G., Corrigall, W. A., Huwyler, J., Malherbe, P., Wyler, R., et al. (2000). Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. The Journal of Pharmacology and Experimental Therapeutics, 294(3), 1112-1119. (Pubitemid 30666867)
59. Hurt, R. D., Krook, J. E., Croghan, I. T., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., et al. (2003). Nicotine patch therapy based on smoking rat followed by bupropion for prevention of relapse to smoking. Journal of Clinical Oncology, 21(5), 914-920. (Pubitemid 46606452)
60. Imperato, A., Mulas, A., & Dichiara, G. (1986). Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. European Journal of Pharmacology, 132 (2-3), 337-338. (Pubitemid 17003483)
61. Irvin, J. E., Hendricks, P. S., & Brandon, T. H. (2003). The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials. Nicotine & Tobacco Research, 5(1), 27-35. (Pubitemid 36285466)
62. Jones, I. W., Bolam, J. P., & Wonnacott, S. (2001). Presynaptic localization of the nicotinic acetylcholine receptor beta 2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurons. The Journal of Comparative Neurology, 439(2), 235-247. (Pubitemid 32906025)
63. Kaiser, S. A., Soliakov, L., Harvey, S. C., Luetje, C. W., & Wonnacott, S. (1998). Differential inhibition by α-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices. Journal of Neurochemistry, 70, 1069-1076. (Pubitemid 28113640)
64. Kenny, P. J., & Markou, A. (2006). Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology, 31, 1203-1211. (Pubitemid 43971837)
65. Klink, R., de Kerchove d'Exaerde, A., Zoli, M., & Changeux, J. P. (2001). Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. Journal of Neuroscience, 21(5), 1452-1463. (Pubitemid 32182187)
66. Koob, G. F. (1992). Neural mechanisms of drug reinforcement. Annals of New York Academy of Sciences, 654, 171-191.
67. Koob, G. F. (1999). The role of the striatopallidal and extended amygdala systems in drug addiction. Annals of New York Academy of Sciences, 877, 445-46.
68. Kulak, J. M., McIntosh, J. M., Yoshikami, D., & Olivera, B. M. (2001). Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels. Journal of Neurochemistry, 77, 1581-1589. (Pubitemid 32574493)
69. Kulak, J. M., Nguyen, T. A., Olivera, B. M., & McIntosh, J. M. (1997). Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. Journal of Neuroscience, 17(14), 5263-5270. (Pubitemid 127777368)
70. Kuryatov, A., Olale, F., Cooper, J., Choi, C., & Lindstrom, J. (2000). Human alpha6 AChR subtypes: subunit composition, assembly and pharmacological responses. Neuropharmacology, 38(13), 2570-2590.
71. Le Novere, N., Zoli, M., & Changeux, J. P. (1996). Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. European Journal of Neuroscience, 8(11), 2428-2439. (Pubitemid 26387904)
72. Liu, X., Caggiula, A. R., Yee, S. K., Nobuta, H., Sved, A. F., Pechnick, R. N., et al. (2007). Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats. Neuropsychopharmacology, 32(3), 710-718.
73. Lopez-Hernandez, G. Y., Sanchez-Padilla, J., Ortiz-Acevedo, A., Lizardi-Ortiz, J., Salas-Vincenty, J., Rojas, L. V., et al. (2004). Nicotine-induced up-regulation and desensitization of alpha4beta2 neuronal nicotinic receptors depend on subunit ratio. Journal of Biological Chemistry, 279(36), 38007-38015. (Pubitemid 39195516)
74. Lundahl, L. H., Henningfield, J. E., & Lukas, S. E. (2000). Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers. Pharmacology, Biochemistry, and Behavior, 66(3), 637-643. (Pubitemid 30440862)
75. Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002). Synaptic mechanisms underlie nicotineinduced excitability of brain reward areas. Neuron, 33(6), 905-919. (Pubitemid 34246356)
76. Mansvelder, H. D., & McGehee, D. S. (2000). Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron, 27(2), 349-357.
77. Mansvelder, H. D., & McGehee, D. S. (2002). Cellular and synaptic mechanisms of nicotine addiction. Journal of Neurobiology, 53(4), 606-617. (Pubitemid 35375590)
78. Markou, A., & Paterson, N. E. (2001). The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine and Tobacco Research, 3(4), 361-373. (Pubitemid 33101063)
79. Martin-Soelch, C., Leenders, K. L., Chevalley, A. F., Missimer, J., Kunig, G., Magyar, S., et al. (2001). Reward mechanisms in the brain and their role in dependence: Evidence from neurophysiological and neuroimaging studies. Brain Research Review, 26(2-3), 139-149. (Pubitemid 33020743)
80. McCallum, S. E., Parameswaran, N., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2005). Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage. Molecular Pharmacology, 68(3), 737-746. (Pubitemid 41206027)
81. McGehee, D. S., Heath, M. J., Gelber, S., Devay, P., & Role, L. W. (1995). Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science, 269(5231), 1681-1682.
82. McGehee, D. S., & Role, L.W. (1995). Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annual Review of Physiology, 57, 521-546.
83. McIntosh, J. M., Olivera, B. M., & Cruz, L. J. (1999). Conus peptides as probes for ion channels. Methods in Enzymology, 294, 605-624.
84. McIntosh, J. M., Santos, A. D., & Olivera, B. M. (1999). Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annual Review of Biochemistry, 68, 59-88. (Pubitemid 29449187)
85. Mihalak, K. B., Carroll, F. I., & Luetje, C.W. (2006). Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Molecular Pharmacology, 70(3), 801-805. (Pubitemid 44268437)
86. Miller, D. K., Sumithran, S. P., & Dwoskin, L. P. (2002). Bupropion inhibits nicotine-evoked [3H]overflow from rat striatal slices preloaded with [3H]dopamine and from rat hippocampal slices preloaded with [3H]norepinephrine. The Journal of Pharmacology and Experimental Therapeutics, 203(3), 1113-1122. (Pubitemid 34920233)
87. Nelson, M. E.,Kuryatov, A.,Choi,C.H., Zhou,Y., & Lindstrom, J. (2003).Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Molecular Pharmacology, 63(2), 332-341. (Pubitemid 36158368)
88. Neugebauer, N. M., Zhang, Z.,Crooks, P.A.,Dwoskin, L. P., & Bardo, M. T. (2006). Effect of a novel nicotinic receptor antagonist, N,N'dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats. Psychopharmacology (Berl), 184(3-4), 426-434. (Pubitemid 43255859)
89. Niaura, R., Shadel, W. G., Abrams, D. B., Monti, P. M., Rohsenow, D. J., & Sirota, A. (1998). Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type. Addictive Behaviors, 23(2), 209-224. (Pubitemid 28136010)
90. Nicke, A., Wonnacott, S., & Lewis, R. J. (2004). Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes. European Journal of Biochemistry, 271(12), 2305-2319. (Pubitemid 38813562)
91. Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994). Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse, 16(1), 36-44. (Pubitemid 24013237)
92. Nomikos ,G. G., Damsma, G., Wenkstern, D., & Fibiger, H. C. (1989). Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology, 2(4), 273-279. (Pubitemid 20025254)
93. Nomikos, G. G., Damsma, G.,Wenkstern, D., & Fibiger, H. C. (1992). Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology, 7(1), 7-14.
94. Palmatier, M. I., Evans-Martin, F. F., Hoffman, A., Caggiula, A. R., Chaudhri, N., Donny, E. C., et al., (2006). Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers. Psychopharmacology, 184, 391-400. (Pubitemid 43255855)
95. Palmatier, M. I., Liu, X., Caggiula, A. R., Donny, E. C., & Sved, A. F. (2007). The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine. Neuropsychopharmacology, 32, 1098-1108. (Pubitemid 46631984)
96. Papke, R. L., Dwoskin, L. P., & Crooks, P. A. (2007). The pharmacological fingerprint of nAChRs subtypes utilizing nicotine and nornicotine: relevance to nicotine dependence and drug discovery. Journal of Neurochemistry, 101(1), 160-167. (Pubitemid 46426475)
97. Perkins, K. A., Epstein, L.H., Grobe, J., & Fonte, C. (1994). Tobacco abstinence, smoking cues, and the reinforcing value of smoking. Pharmacology, Biochemistry, and Behavior, 47(1), 107-112.
98. Picciotto, M. R., Zoli, M., Rimondini, R., Lena, C., Marubio, L. M., Pich, E. M., et al. (1998). Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature, 391(6663), 173-177. (Pubitemid 28092475)
99. Pidoplichko, V. I., DeBiasi,M.,Williams, J. T., & Dani, J. A. (1997). Nicotine activates and desensitizes midbrain dopamine neurons. Nature, 390(6658), 401-404. (Pubitemid 28027320)
100. Pidoplichko, V. I., Noguchi, J., Areola, O. O., Liang, Y., Peterson, J., Zhang, T., et al. (2004). Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learning and Memory, 11(1), 60-69. (Pubitemid 38167059)
101. Pivavarchyk, M., Zhang, Z., Crooks, P. A., & Dwoskin, L. P. (2007). Tetrakis quaternary ammonium salts: novel nicotinic receptor antagonists which inhibit nicotine-evoked [3H]dopamine overflow from superfused rat striatal slices. Society for Neuroscience Abstract, 37, 7812.
102. Pomerleau, C. S., & Pomerleau, O. F. (1992). Euphoriant effects of nicotine in smokers. Pychopharmacology (Berl), 108, 460-465.
103. Pontieri, F. E., Tanda, G., Orzi, F., & Di Chiara, G. (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature, 382(6588), 255-257. (Pubitemid 26251360)
104. Poth, K., Nutter, T. J., Cuevas, J., Parker, M. J., Adams, D. J., & Luetje, C.W. (1997). Heterogeneity of nicotinic receptor class and subunit mRNA expression among individual parasympathetic neurons from rat intracardiac ganglia. Journal of Neuroscience, 17(2), 586-596. (Pubitemid 27024571)
105. Quarta, D., Ciruela, F., Patkar, K., Borycz, J., Solinas, M., Lluis, C., et al. (2007). Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release. Neuropsychopharmacology, 32(1), 35-42. (Pubitemid 44967782)
106. Rahman, S., Neugebauer, N. M., Zhang, Z., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2007). The effects of a novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens. Neuropharmacology, 52(3), 755-763. (Pubitemid 46227466)
107. Rahman, S., Zhang, J., & Corrigall, W. A. (2004). Effects of nicotine preexposure on sulpirideinduced dopamine release in the nucleus accumbens. European Journal of Pharmacology, 494(1), 31-34. (Pubitemid 38759828)
108. Rahman, S., Zhang, Z., Papke, R. L., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2008). Regionspecific effects of N,N'dodecane-1,12-diyl-bis-3- picolinium dibromide (bPiDDB) on nicotineinduced increase in extracellular dopamine in vivo. British Journal of Pharmacology, 153, 792-804. (Pubitemid 351271759)
109. Rauhut, A. S., Neugebauer, N., Dwoskin, L. P., & Bardo, M. T. (2003). Effect of bupropion on nicotine self-administration in rats. Psychopharmacology (Berl), 169, 1-9. (Pubitemid 37088608)
110. Rice, M. E., & Cragg, S. J. (2004). Nicotine amplifies reward-related dopamine signals in striatum. Nature Neuroscience, 7(6), 583-584. (Pubitemid 38691894)
111. Rose, J. E., & Behm, F. M. (2004). Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine & Tobacco Research, 6(3), 523-532. (Pubitemid 38967541)
112. Rose, J. E., Behm, F. M., Westman, E. C., Levin, E. D., Stein, R. M., & Ripka, G. V. (1994). Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clinical Pharmacology and Therapeutics, 56(1), 86-99. (Pubitemid 24251569)
113. Rose, J. E., Westman, E. C., Behm, F. M., Johnson, M. P., & Goldberg, J. S. (1999). Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. Pharmacology, Biochemistry, and Behavior, 62(1), 165-172. (Pubitemid 29017770)
114. Salminen, O., Drapeau, J. A., McIntosh, J. M., Collins, A. C., Marks, M. J., & Grady, S. R. (2007). Pharmacology of α-conotoxinMII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Molecular Pharmacology, 71, 1563-1571. (Pubitemid 47010909)
115. Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., et al. (2004). Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Molecular Pharmacology, 65, 1526-1535. (Pubitemid 38668310)
116. Scholze, P., Orr-Urtreger, A., Changeux, J. P., McIntosh, J. M., & Huck, S. (2007). Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation. British Journal of Pharmacology, 151(3), 414-422. (Pubitemid 46842677)
117. Shima, K., & Tanji, J. (1998). Role for cingulated motor area cells in voluntary movement selection based on reward. Science, 282, 1335-1338. (Pubitemid 28524499)
118. Singer, G., Wallace, M., & Hall, R. (1982). Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the rat. Pharmacology, Biochemistry, and Behavior, 17(3), 579-581. (Pubitemid 12037675)
119. Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000). Bupropion is a nicotinic antagonist. The Journal of Pharmacology and Experimental Therapeutics, 295(1), 321-327.
120. 2+ channels involved in nicotinic receptor-mediated [3H]dopamine release from rat striatal synaptosomes. Journal of Neurochemistry, 67, 163-170.
121. Spanagel, R., & Weiss, F. (1999). The dopamine hypothesis of reward: past and current status. Trends in Neuroscience, 22(11), 521-527. (Pubitemid 29481853)
122. Stokes, C., Dwoskin, L. P., Crooks, P. A., Jacobs, L. B., McIntosh, J.M., & Papke, R. L. (2007). The identification of selective competitive and noncompetitive nAChR antagonists using alpha6 nicotinic acetylcholine receptor chimeras. Society for Neuroscience Abstract, 37, 5744.
123. Stolerman, I. P., & Jarvis, M. J. (1995). The scientific case that nicotine is addictive. Psychopharmacology, 117(1), 2-10.
124. Sumithran, S. P., Crooks, P. A., Xu, R., Zhu, J., Deaciuc, A. G., Wilkins, L. H., et al. (2005). Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity. American Association of Pharmaceutical Scientists Journal, 7(1), E201-217. (Pubitemid 41554288)
125. Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., et al. (2004). Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science, 306(5698), 983-985.
126. Teng, L., Crooks, P. A., Buxton, S. T., & Dwoskin, L. P. (1997). Nicotinic-receptor mediation of S(-)nornicotine-evoked [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake. The Journal of Pharmacology and Experimental Therapeutics, 280(3), 1432-1444. (Pubitemid 27166742)
127. Vann, R. E., Rosecrans, J. A., James, J. R., Philibin, S. D., & Robinson, S. E. (2006). Neurochemical 1and behavioral effects of bupropion and mecamylamine in the presence of nicotine. Brain Research, 1117, 18-24. (Pubitemid 44573094)
128. Wada, E., McKinnon, D., Heinemann, S., Patrick, J., & Swanson, L. W. (1990). The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor family (alpha 5) in the rat central nervous system. Brain Research, 526(1), 45-53. (Pubitemid 20273561)
129. Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J., et al. (1989). Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. The Journal Comparative Neurology, 284(2), 314-335. (Pubitemid 19185398)
130. Walters, C. L., Brown, S., Changeux, J. P., Martin, B., & Damaj, M. I. (2006). The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology, 184(3-4), 339-344. (Pubitemid 43255850)
131. Wei, X., Sumithran, S. P., Deaciuc, A. G., Burton, H. R., Bush, L. P., Dwoskin, L. P., et al. (2005). Identification and synthesis of novel alkaloids from the root system of Nicotiana tabacum: Affinity for neuronal nicotinic acetylcholine receptors. Life Sciences, 78, 495-505. (Pubitemid 41653499)
132. Whiteaker, P., Marks, M. J., Grady, S. R., Lu, Y., Picciotto, M. R., Changeux, J. P., et al. (2000). Pharmacological and null mutation approaches reveal nicotinic receptor diversity. European Journal of Pharmacology, 393(1-3), 123-135. (Pubitemid 30193408)
133. Wilkins, L. H., JR., Grinevich, V. P., Ayers, J. T., Crooks, P. A., & Dwoskin, L. P. (2003). N-n-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with α4β2* and α7* neuronal nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics, 304(1), 400-410. (Pubitemid 36008954)
134. 3H]dopamine overflow
135. Wilkins, L. H., Miller, D. K., Ayers, J. T., Crooks, P. A., & Dwoskin, L. P. (2006). N-n-Alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomes. American Association of Pharmaceutical Scientists Journal, 7(4), E922-930.
136. Wise, R. A. (1996). Neurobiology of addiction. Current Opinion in Neurobiology, 6(2), 243-251. (Pubitemid 26168484)
137. Wise, R. A. (2000). Addiction becomes a brain disease. Neuron, 26, 27-33.
138. Wise, R. A., & Bozarth,M. A. (1987). A psychomotor stimulant theory of addiction. Psychological Review, 94(4), 469-492.
139. Wonnacott, S. (1997). Presynaptic nicotinic Ach receptors. Trends in Neuroscience, 20(2), 92-98. (Pubitemid 27050704)
140. Wonnacott, S., Kaiser, S., Mogg, A., Soliakov, L., & Jones, I. W. (2000). Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. European Journal of Pharmacology, 393(1-3), 51-58. (Pubitemid 30193400)
141. Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005). Nicotine: from molecular mechanisms to behaviour. Current Opinion in Pharmacology, 5(1), 53-59. (Pubitemid 40124535)
142. Wooltorton, J. R.A., Pidoplichko, V. I., Broide, R. S., & Dani, J. A. (2003). Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. Journal of Neuroscience, 23(8), 3176-3185.
143. Zheng, F., Bayram, E., Sumithran, S. P., Ayers, J. T., Zhan, C. G., Schmitt, J. D., et al. (2006). QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release. Bioorganic & Medicinal Chemistry, 14(9), 3017-3037.
144. Zhang, Z., Lockman, P. R., Geldenhuys,W. J., Allen, D. D., Dwoskin, L. P., & Crooks, P. A. (2005). Synthesis of bis-pyridinium analogs and structurally related cyclophanes with high affinity for the blood brain barrier choline transporter. American Association Pharmaceutical Scientists, PharmSci (Supplement), 7(S2), Abstract W4079.
145. Zhou, F. M., Liang, Y., & Dani, J. A. (2001). Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nature Neuroscience, 4(12), 1224-1229. (Pubitemid 33135628)
146. Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002). Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. Journal of Neuroscience, 22(20), 8785-8789. (Pubitemid 35379047)
147. Zwart, R., & Vijverberg, H. P. (1998). Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Molecular Pharmacology, 54(6), 1124-1131. (Pubitemid 29002058)